Want to use our logo?

Download the ICS Branding Pack

ICS Background

Dr Sajjad Rahnama'i
Nijsmellinghe

ICS 2021

Open Discussion Session 15 On Demand Continence Care Products / Devices / Technologies 140 Effectivity and safety of a new implantable tibial nerve stimulation device (STIMROUTER) for the treatment of overactive bladder syndrome: 12 months results of a multi-centre study

Open Discussion Session 26 On Demand Overactive Bladder 395 Obsessive bladder: a preliminary description of characteristic lower urinary tract symptoms and urodynamic patterns among women with obsessive-compulsive disorder and chronic LUTS

Open Discussion Session 31 On Demand Prevention and Public Health 486 Lower Urinary Tract Signs and Symptoms in COVID-19 infected Patients

ICS 2019

Podium Short Oral Session 4 Nocturia 41 The Effect of Sacral Neuromodulation (SNM) during the Tined Lead Procedure (TLP) on Nocturia in Patients with Overactive Bladder Syndrome (OAB)

Open Discussion Session 31 E-Poster 3 602 Urinary Microbiome and Its Correlation with Functional Disorders of the Genitourinary Tract

Non Discussion Abstract Session 37 Non Discussion Abstract 766 The Effect of Sacral Neuromodulation (SNM) on Nocturia

ICS 2018

Open Discussion Session 28 Open Discussion ePosters 500 The Urodynamic Effect of Cerebrolysin in after Spinal Cord Injured Female Wistar Rats

Non Discussion Abstract Session 36 Non Discussion Abstracts 703 Intravesical Abobotulinum toxin A Injection for Patients with Detrusor Overactivity - 5 year follow up results

ICS 2017

Podium Short Oral Session 34 Basic Science 3 576 Functional connectivity of brain areas involved in bladder filling Sensation using 7 Tesla Magnetic Resonance Imaging

Open Discussion Session 35 Open Discussion ePosters 3 627 Gender Differences in Prevalence of Nocturia in Patients with Obstructive Sleep Apnea Syndrome (OSAS)

Open Discussion Session 35 Open Discussion ePosters 3 653 Long Term Compliance and Results of Intravesical Botulinum Toxin A Injections in Male Patients

Non Discussion Abstract Session 41 Non Discussion Abstracts 816 Patients Reluctance to Visit a Doctor for Nocturia

ICS 2016

Podium Short Oral Session 2 Environmental and Metabolic Factors in Female Pelvic Floor Dysfunction Reduction of Nocturia in Patients Treated with C-PAP for Obstructive Sleep Apnea Syndrome

ICS 2014

Podium Poster Session 20 Lower Urinary Tract Symptoms in Women 1 331 Multicenter Analysis of 10 Years Follow up after Repeat Intravesical Botulinum toxin-A Injections in Patients with Detrusor Overactivity

Open Discussion Poster Session 31 Basic Science 447 Phosphodiesterase Type 2 (PDE2) Expression on Nerves and Interstitial Cells of the Guinea Pig Urinary Bladder

ICS 2012

Non Discussion Poster Session 31 361 EFFECTIVITY AND COMPLICATIONS OF REPEATED BOTULINUM TOXIN-A INJECTIONS IN PATIENTS WITH THERAPY RESISTENT DETRUSOR OVERACTIVITY

ICS 2011

Non Discussion Poster Session 29 326 The distribution of the prostaglandin E receptors type 1 and 2 in the obstructed human urinary bladder

ICS/IUGA 2010

Non Discussion Abstract Session 33 Read by Title 1040 The role of prostaglandins in the muscarinic response in the isolated normal guinea pig bladder

Non Discussion Abstract Session 33 Read by Title 1043 The first indication of Phosphodiesterase type 2 presence in the Guinea Pig Bladder

ICS 2009

Podium Poster Session 18 Detrusor Overactivity Non-Clinical 191 EVIDENCE FOR PROSTAGLANDIN INVOLVEMENT IN NEURO-MODULATION IN THE GUINEA PIG BLADDER

View ICS Editor-In-Chief Details

Sajjad Rahnama'i

ICS Editor-In-Chief

Profession:Urologist
Qualifications:PhD Staff Member
Privacy:
You must be logged in to view this contact
Sign-in to ICS

Mohammad Sajjad Rahnama’i is born on May 18th 1979 in Tehran (Iran). After finishing elementary
school at the age of 12 in Iran, his family emigrated to the Netherlands, where he was sent to
the school for basic technical skills (LTS, Delta college in Brunssum), like all newly arrived, foreign
children. After figuring out the Dutch school system, he changed to a higher
level, in order to gain access to the university and study medicine. After 1 year of LTS and
1 year at a middle level high school MAVO, he was able to convince the school board to make
an exception and let him attend the Dutch grammar school (Atheneum, Rombouts College in
Brunssum), from which he graduated in 1998. In that year, his name did not turn up at the Dutch
national lottery for entering medical school. He therefore took the entrance exam and entered the medical school (Diepenbeek, Belgium).
He graduated in the first year with honours and returned to the medical faculty of the Maastricht
University in 1999, from where he graduated his bachelor in 2003 and master in 2005, both with
honours degree. He started his clinical work as a medical doctor at the intensive care unit in Heerlen
followed by one year at the surgery department in Sittard. In 2007, he started his PhD research at
the urology department in Maastricht, under the supervision of Prof. Van Kerrebroeck, Dr. Van
Koeveringe and Prof. Gillespie from Newcastle (United Kingdom). In 2008, he received a personal
Mozaïek grant from the Netherlands Organization for Scientific Research (NWO). He was accepted
in the Dutch urology resident program in 2009 and started his training in 2011.
He finalized and defended his PhD in november 2013 Cum Laude.
Beside his research, he is a member of the city counsel of his hometown Heerlen from 2006 and has taken part in Persian music ensembles. He is a proud father of 2 sons and 2 daughters: Behzad, Niekdad, Dorzad and Mehrzad, born in '08, '10, '13 and '15 respectively.

Dr Sajjad Rahnama'i declared on the Tuesday 9th January 2024 that they had the following existing or known future financial relationships or affiliations:

Editor in chief Continence Reports

  • Other: edior

Society of Urological Research and Education (SURE)

  • Director or employee
  • Other: Chairman
UP TO DATE!